No Picture
News

Active Motif and EpiCypher Execute Cross-Licensing Agreement and End Ongoing Litigation Involving Targeted Transposition/CUT&Tag Technology for Epigenomics

CARLSBAD, Calif. and RESEARCH TRIANGLE PARK, N.C., Aug. 1, 2022 /PRNewswire/ — CUT&Tag is a targeted transposition technique that allows high-resolution genomic mapping of histone modifications and chromatin-associated proteins through the precise insertion of DNA […]

No Picture
News

SEVEN RESEARCHERS HONORED FOR SCIENTIFIC ACHIEVEMENTS AND CONTRIBUTIONS TO THE DEMENTIA FIELD AT ALZHEIMER’S ASSOCIATION INTERNATIONAL CONFERENCE

SAN DIEGO, July 31, 2022 /PRNewswire/ — The Alzheimer’s Association® will present seven awards at the Alzheimer’s Association International Conference® (AAIC®) 2022, recognizing researchers for their varied expertise, noteworthy achievements and innovative contributions to the […]

No Picture
News

C2N’s New Blood Test Combining p-tau217 Ratio with A?42/40 Ratio Points to Accuracy Levels Comparable to Existing Standards of Care for Amyloid Diagnosis in the Evaluation of Patients with Cognitive Impairment

SAN DIEGO–(BUSINESS WIRE)– #AAIC2022–Data released from C2N Diagnostics, presented today at the Alzheimer’s Association International Conference, demonstrated that a blood test combining the A?42/40 ratio, a component of C2N’s commercially available PrecivityADTM blood test, with […]

No Picture
News

ALZHEIMER’S ASSOCIATION GLOBAL WORKGROUP RELEASES RECOMMENDATIONS ABOUT USE OF ALZHEIMER’S “BLOOD TESTS”

FROM THE ALZHEIMER’S ASSOCIATION INTERNATIONAL CONFERENCE 2022 Top Tier Clinicians and Researchers Find the Tests Are: – Full of Revolutionary Potential – Valuable Now For Research and Treatment Trials – Not Ready Yet for the […]

No Picture
News

Evofem Biosciences Commends Tri-Agencies for Clarifying that Contraceptives Must be Covered at No Cost to Individuals

SAN DIEGO, July 29, 2022 /PRNewswire/ — Evofem Biosciences, Inc., (Nasdaq: EVFM), a women’s healthcare company, today commended the U.S. Department of Health and Human Services, alongside the Departments of Labor and of the Treasury […]

No Picture
News

Aethlon Medical Announces Publication of Peer-Reviewed Journal Article Describing Hemopurifier Resin Binding of Seven COVID-19 Variants

SAN DIEGO, July 28, 2022 /PRNewswire/ — Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to diagnose and treat cancer and life threatening infectious diseases, today announced the publication of […]

No Picture
News

VyTrac Announces Pulmonary Intensive Care Unit Physician and Digital Health Champion Dr. Venktesh Ramnath to Join as Strategic Advisor

LOS ANGELES, July 28, 2022 /PRNewswire/ — VyTrac Health, Inc. (VyTrac), a leader in Remote Patient Monitoring (RPM) digital health technologies, announced today that Dr. Venktesh Ramnath, MD, an Intensive Care Unit Pulmonologist and a […]

No Picture
News

Innovate to Dominate

A new book from Tai Ming Cheung, “Innovate to Dominate: The Rise of the Chinese Techno-Security State,” examines the convergence of national security, innovation and economic development in China, detailing the … […]

No Picture
News

Innovate to Dominate

A new book from Tai Ming Cheung, “Innovate to Dominate: The Rise of the Chinese Techno-Security State,” examines the convergence of national security, innovation and economic development in China, detailing the … […]

No Picture
News

First Patient Dosed in the ENLIGHTEN Biomarker-Guided Global Clinical Trial of DB104 (Liafensine) for Treatment-Resistant Depression

SAN DIEGO, July 28, 2022 /PRNewswire/ — Denovo Biopharma LLC (“Denovo”), a pioneer in applying precision medicine to the development of innovative therapies, today announced dosing of the first patient in its biomarker-guided global Phase […]

No Picture
News

Evofem Biosciences to Report Second Quarter 2022 Results and Provide Corporate Update on Thursday, August 4, 2022

— Conference Call Scheduled for 5:00 p.m. ET — SAN DIEGO, July 28, 2022 /PRNewswire/ — Evofem Biosciences, Inc., (Nasdaq: EVFM) will hold a webcast and conference call to discuss financial results and business highlights […]

No Picture
News

Crown Bioscience Appoints Michael Prosser as Chief Business Officer and Illustrates Further Investment in Commercial Leadership

SAN DIEGO–(BUSINESS WIRE)–Crown Bioscience, a JSR Life Sciences company, announced today that it has restructured its commercial leadership team by creating a new Chief Business Officer (CBO) role and with additional investment in commercial talent. […]

No Picture
News

Genentech to Present Scientific Progress Across Alzheimer’s Disease Pharmaceutical and Diagnostic Portfolio at 2022 AAIC Annual Meeting

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that data from 41 abstracts across its portfolio of Alzheimer’s disease pharmaceuticals and diagnostics will be presented […]